Research & Education
CURE Expert Connections
CURE Speaking Out
Ovarian Cancer Heroes
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
See all >
Acute Myeloid Leukemia
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
See all >
EDUCATED PATIENT SUMMIT: Lung Cancer
AWARD PROGRAM: Lung Cancer Heroes
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Gut Microbiome May Play an Important Role in Immunotherapy in the Future, But More Research is Needed
The microorganisms inside a patient's gastrointestinal tract may have a role to play in how immunotherapy can treat certain types of cancer.
Immunotherapy Use Not Associated with Increased Risk of Death in Patients with Cancer and COVID-19
More than half of the patients (61%) admitted to either the hospital or ICU were discharged and 12% remained in the hospital. Nine patients had died by the time data collection was cut off for this study.
Exciting Treatment Harnesses the Immune System
Debu Tripathy, M.D.
Immunotherapy is a wonderful testament to the benefits that arise from our growing understanding of the incredibly intricate human immune system.
FDA Approvals of Immunotherapy Keep Coming, Even at This Challenging Moment
Mike Hennessy Sr., Chairman and Founder
In the 2020 special issue of CURE on Immunotherapy, we take a look at how the field of immunotherapy continues to grow despite challenges from the COVID-19 pandemic.
Staying Informed and Empowered as A Patient with Cancer
Cancer Research Institute
Cutting-edge medical information and first-person accounts empower patients to evaluate immunotherapy as a treatment option, one organization attests.
Unleashing the Power Within Using Tumor-Infiltrating Lymphocyte Therapy
Across cancer types, a unique immune-stimulating treatment called tumor-infiltrating lymphocyte therapy produces durable remissions that could last for decades.
Identifying Opportunities of Treatment From RNA Expressions
Beth Fand Incollingo
A new tool analyzes patterns of RNA expressed from genes, pinpointing more patients with cancer who can benefit from immunotherapies and targeted drugs.
New Immunotherapy Combinations Look to Create Maximum Velocity in Immune Systems Response to Cancer
New immunotherapy combinations aim to turbocharge the immune system’s attack against cancer.
Good News For Rare Cancer Treatment, Keytruda Can Help
Immunotherapy with Keytruda shows promise in advanced uncommon cancers in which new treatment options are needed.
The Future of CSCC Management
Key opinion leaders close the discussion by considering the future of cutaneous squamous cell carcinoma (CSCC) and promising emerging regimens.
Not a member?
Sign up now!
Continue without login